Prof. Christian Langbein, LLM
Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references The core element of a patent or technology transaction lies in its focus on the transfer of specific intellectual property (IP) and associated technologies, rather than the acquisition of an entire company. Intellectual property transactions are particularly relevant in the healthcare and life sciences sectors, covering areas such as medical technology (e.g., devices, products, robotics, and laboratory innovations), health IT (including telemedicine, medical software, artificial intelligence, and data solutions), pharmaceuticals and biotechnology.
The Importance of Intellectual Property Transactions in Healthcare
In the highly regulated and innovation-driven healthcare industry, intellectual property is far more than a legal formality but it is a strategic asset. Patents, licenses, trade secrets, copyrights and proprietary technologies serve as critical levers for protecting innovation, securing defensible competitive positions, and attracting capital for ongoing R&D.
There are scenarios in which valuable technologies are developed within organizations that are either strategically misaligned or operationally unprepared to commercialize them. In such cases, monetizing non-core or underutilized IP, whether through an outright sale or through licensing, can be both rational and accretive to enterprise value.
From the acquirer's perspective, the calculus is equally straightforward: how does one access differentiated technologies that create shareholder value, without enduring the cost, risk, and timeline of internal development? In many instances, the answer is self-evident: buy rather than build.
This mindset aligns two motivated parties — one seeking to unlock value from IP, and the other intent on gaining a competitive edge through acquisition.
ConAlliance's role is to bring these parties together, structure a deal that reflects the true value of the asset, and ensure execution with precision. ConAlliance has successfully advised numerous M&A projects in this context, both on the sell-side and the buy-side and combines technical acuity, sectoral depth, and transactional sophistication to deliver outcomes that redefine how healthcare IP is monetized and mobilized.
Outlook to Cooperations and Licensing
Beyond outright sales, alternative transaction structures such as strategic partnerships or licensing agreements are often employed to unlock mutual value while maintaining flexibility. Mastery of these nuanced transaction types demands a deep understanding of both the market dynamics and the intellectual property landscape, ensuring the strategic alignment of assets with overarching corporate goals. This approach underscores the sophisticated nature of such deals and reflects the precision and expertise required to navigate them effectively.
More information on Cooperations & Licensing in Healthcare M&A
